The Cigna Group

What does The Cigna Group own?
The Cigna Group owns Cigna Healthcare (health insurance products including medical, dental, behavioral health, and vision plans), Express Scripts (pharmacy benefits management), Evernorth Health Services (specialty pharmacy and care coordination), Cigna Dental, Cigna Pharmacy, and Cigna Global Health Benefits. In 2025, the company sold its Medicare Advantage, Medicare Supplemental Benefits, Medicare Part D, and CareAllies businesses to Health Care Service Corporation.

Is The Cigna Group publicly traded?
Yes, The Cigna Group is publicly traded on the New York Stock Exchange under ticker symbol CI. The company has been publicly traded since its formation in 1982 and is a component of the S&P 500 Index, ranked No. 13 on the Fortune 500.

Who founded The Cigna Group?
The Cigna Group was founded in 1982 through the merger of Connecticut General Life Insurance Company (founded 1865 in Hartford, Connecticut) and Insurance Company of North America (founded 1792 in Philadelphia, one of the oldest insurance companies in America). The company was renamed The Cigna Group in February 2023.

Where is The Cigna Group headquartered?
The Cigna Group is headquartered at 900 Cottage Grove Road, Bloomfield, Connecticut 06002, USA. The company operates in more than 30 markets and jurisdictions worldwide.

How many brands does The Cigna Group own?
The Cigna Group's principal brands are Cigna Healthcare, Express Scripts, and Evernorth Health Services. These umbrella brands cover health insurance, pharmacy benefits management, dental insurance, pharmacy services, and international health benefits.

Who owns The Cigna Group?
The Cigna Group is publicly owned with a dispersed shareholder base. Institutional investors hold the majority of shares, with no single controlling shareholder. Major institutional shareholders include Vanguard Group, BlackRock, and State Street Global Advisors, typical of S&P 500 companies.

What is The Cigna Group's revenue?
For FY2025, The Cigna Group reported total revenues of $274.9 billion, up 11% from $247.1 billion in FY2024. Shareholders' net income was $6.0 billion, or $22.18 per share. Adjusted income from operations was $8.0 billion, or $29.84 per share. For 2026, the company projects adjusted revenues of approximately $280 billion.

Has The Cigna Group made major changes recently?
Yes. In March 2025, Cigna completed the sale of its Medicare Advantage and related businesses to HCSC. In October 2025, Express Scripts announced a new rebate-free PBM model. In February 2026, Express Scripts reached a landmark settlement with the FTC over insulin pricing practices. The company also increased its quarterly dividend to $1.56 per share.

The Cigna Group traces its origins to 1982 when Connecticut General Life Insurance Company (CG), founded in 1865 in Hartford, Connecticut, merged with Insurance Company of North America (INA), established in 1792 in Philadelphia. INA was one of the oldest insurance companies in America. The merger created Cigna, a diversified insurance and healthcare company.

Through the 1980s and 1990s, Cigna expanded through acquisitions and diversification into various insurance and healthcare services. The company grew its international operations and expanded into managed healthcare, pharmacy benefits management, and other health-related services.

In 2018, Cigna completed a landmark $67 billion acquisition of Express Scripts, one of the largest pharmacy benefits management companies in the United States. This acquisition transformed Cigna from a traditional health insurer into a comprehensive healthcare services company with significant capabilities in pharmacy benefits management. Express Scripts manages prescription drug benefits for millions of Americans and is one of the three largest PBMs in the country, controlling approximately 80% of prescriptions filled in the United States alongside Optum Rx and CVS Caremark.

In February 2023, the company changed its name from Cigna Corporation to The Cigna Group to better reflect its diverse portfolio of businesses and global healthcare services. The rebranding emphasized the company's evolution beyond traditional health insurance into a broader healthcare services organization.

In March 2025, The Cigna Group completed the sale of its Medicare Advantage, Medicare Individual Stand-Alone Prescription Drug Plans, Medicare and Other Supplemental Benefits, and CareAllies businesses to Health Care Service Corporation (HCSC). The divestiture streamlined Cigna's portfolio and allowed the company to focus on its commercial health insurance and pharmacy benefits management businesses. Proceeds from the sale were primarily allocated to share repurchases.

In February 2026, Express Scripts reached a landmark settlement with the Federal Trade Commission to resolve allegations that the company artificially inflated the price of insulin through rebate tactics. The settlement requires Express Scripts to change how it calculates prices for its approved drug list, no longer favoring drugs with high list prices when cheaper equivalents exist. The settlement included no monetary penalties and Express Scripts did not admit wrongdoing. The company had already been transitioning to a new rebate-free PBM model announced in October 2025, which aligns with the settlement requirements.

The Cigna Group maintains a comprehensive ESG framework organized under four pillars: Healthy Society, Healthy Workforce, Healthy Environment, and Healthy Company.

Healthy Society focuses on delivering sustainable healthcare services, improving health outcomes, addressing health disparities, and supporting community resilience through disaster response and health equity investments.

Healthy Workforce includes employee health and safety programs, diversity and inclusion initiatives, human capital development, and community engagement through paid volunteer time off.

Healthy Environment covers climate change risk assessment, emissions reduction, LEED-certified facilities, and supply chain sustainability.

Healthy Company encompasses corporate governance, business ethics, compliance programs, data protection, and responsible supply chain management.

The company publishes comprehensive sustainability reports and participates in various ESG rating systems. The Cigna Group is not a Certified B Corporation. Its sustainability reporting is primarily self-reported through corporate communications and SEC filings.

The Cigna Group has received recognition for its enterprise performance, workplace excellence, and ESG leadership:

• Fortune 500 (2025): Ranked No. 13 on the list of largest U.S. corporations by revenue
• Fortune Global 500: Ranked among the top 500 companies worldwide by revenue
• Fortune World's Most Admired Companies: Recognized by industry peers for corporate reputation
• Fair360 Top 50 Companies: Ranked No. 7 for workplace practices and talent programs
• Human Rights Campaign Equality 100 Award: Perfect score for LGBTQ+ workplace equality
• Disability Equality Index: Recognition for disability inclusion and accessibility

These recognitions are based on independent rankings and media reporting, not self-awarded claims.

The Cigna Group has faced significant regulatory and public scrutiny, primarily related to its pharmacy benefits management business through Express Scripts.

In September 2024, the Federal Trade Commission sued Express Scripts, along with Optum Rx and CVS Caremark, alleging that the PBMs artificially inflated the cost of insulin through rebate tactics. In February 2026, Express Scripts reached a landmark settlement with the FTC, agreeing to change its drug pricing practices, no longer favoring high-list-price drugs on standard formularies, delinking compensation from drug list prices, and increasing transparency. The settlement included no monetary penalties and Express Scripts did not admit wrongdoing. The FTC estimated the settlement could reduce patients' out-of-pocket drug costs by up to $7 billion over a decade.

In October 2025, Cigna announced its decision to end drug rebates and move to a transparent, fee-based PBM model. The announcement, along with concessions to its largest clients, caused the stock to decline sharply, its worst slide since 2008. CEO David Cordani later quantified the earnings impact at $500 million to $600 million during a congressional hearing on healthcare affordability in January 2026.

The Cigna Group was previously in merger discussions with Humana, which were called off in late 2023. Following the failed merger, Cigna pivoted to divesting its Medicare Advantage business and focusing on commercial insurance and pharmacy services.

As a health insurer and PBM, The Cigna Group is subject to extensive regulation including the Affordable Care Act, Medicare and Medicaid regulations, state insurance department oversight, HIPAA, and FTC antitrust enforcement. The company must comply with medical loss ratio requirements, pharmacy benefit transparency rules, and data privacy standards.